MCCLUNG BARBARA G 4
4 · Caribou Biosciences, Inc. · Filed Sep 16, 2022
Insider Transaction Report
Form 4
MCCLUNG BARBARA G
Chief Legal Officer
Transactions
- Exercise/Conversion
Common Stock
2022-09-15$2.69/sh+77$207→ 349,048 total - Exercise/Conversion
Common Stock
2022-09-15$2.69/sh+27,518$74,023→ 376,566 total - Exercise/Conversion
Option to purchase Common Stock
2022-09-15−27,518→ 47,318 totalExercise: $2.69Exp: 2029-09-30→ Common Stock (27,518 underlying) - Exercise/Conversion
Option to purchase Common Stock
2022-09-15−77→ 0 totalExercise: $2.69Exp: 2028-06-11→ Common Stock (77 underlying)
Footnotes (2)
- [F1]The shares subject to this option vested in equal monthly installments until the option became fully vested on June 12, 2022.
- [F2]The shares subject to this option have vested or will vest in equal monthly installments until the option is fully vested on October 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.